Pharmaguy's Insights Into Drug Industry News
194.6K views | +3 today
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy!

Morning Sickness = Lower Risk of Pregnancy Loss. Diclegis Use = Higher Risk?

A new analysis by researchers at the National Institutes of Health has provided the strongest evidence to date that nausea and vomiting during pregnancy is associated with a lower risk of miscarriage in pregnant women. The study, appearing in JAMA Internal Medicine, was conducted by researchers at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and other institutions.


Nausea and vomiting that occurs in pregnancy is often called “morning sickness,” as these symptoms typically begin in the morning and usually resolve as the day progresses. For most women, nausea and vomiting subside by the 4th month of pregnancy. Others may have these symptoms for the duration of their pregnancies. The cause of morning sickness is not known, but researchers have proposed that it protects the fetus against toxins and disease-causing organisms in foods and beverages.


“It’s a common thought that nausea indicates a healthy pregnancy, but there wasn’t a lot of high-quality evidence to support this belief,” said the study’s first author, Stefanie N. Hinkle, Ph.D, a staff scientist in NICHD’s Epidemiology Branch. “Our study evaluates symptoms from the earliest weeks of pregnancy, immediately after conception, and confirms that there is a protective association between nausea and vomiting and a lower risk of pregnancy loss.”

No comment yet.
Scooped by Pharma Guy!

Former "Bachelorette" Emily Maynard Says "Yes" to Diclegis Deal Months After Tweeting This

Former "Bachelorette" Emily Maynard Says "Yes" to Diclegis Deal Months After Tweeting This | Pharmaguy's Insights Into Drug Industry News |

ROSEMONT, PAJune 28, 2016 /PRNewswire/ - Today, [Duchesnay USA] announced a partnership with TV Personality and New York Times Best-Selling Author [of book "I Said Yes"], Emily Maynard Johnson, to raise awareness about Morning Sickness and treatment options.

Best known for her appearance on "The Bachelor" and "The Bachelorette", Emily is a wife, mother of two and lifestyle expert. Upon learning she was expecting her third child, Emily was thrilled. However, she became concerned about juggling her family, personal life and career, while experiencing Morning Sickness, which she had struggled with throughout her previous pregnancies.

"This time around, it was really important for me to find a way to feel better and enjoy my pregnancy", said Emily.

After modifying her diet, her lifestyle and trying various prescription treatment options without success, Emily turned to Twitter, asking for suggestions to help manage her Morning Sickness. That's where she learned about Diclegis®, the only FDA-approved and only Pregnancy Category A prescription medication for Morning Sickness after diet and lifestyle changes have failed.

"I'm grateful to have found Diclegis®, which has helped me manage my Morning Sickness. I encourage all expectant moms who have Morning Sickness to stop suffering in silence! Ask your healthcare provider if Diclegis® is right for you like I did", advises Emily.

Pharma Guy's insight:

This is just another example* of a celebrity that auditioned for the part before signing the contract. The tweet shown here was made by Emily on 18 Mar 2016 and the deal was announced on 28 June 2016. Unlike Kim Kardashian, who posted a violative Diclegis promo on Instagram after signing on as a spokesperson (read "OMG. Kim Kardashian Shills for Pharma! No Worry - No Side Effects!";, Emily is not likely to make similar tweets like the one she did before signing on with Duchesnay. 


*Read “Is Phil Mickelson Shilling for Enbrel?”;

Pharma Guy's curator insight, July 4, 2016 8:18 AM

By now you've probably heard about Kim Kardashian's enthusiastic Instagram post promoting Diclegis (see here: That post violated FDA regulations because, like Maynard's post, it did not mention side effects. Consequently, FDA sent a warning letter to Duchesnay. The difference here is that Maynard was not employed as a Diclegis spokesperson when she made her tweet. But the questions remains: Was she in talks with Duchesnay at the time? And was the tweet a "freebie"? It wouldn't be the first time that a celebrity enthusiastically endorsed a product just before signing on as an official spokesperson (see, for example, “Is Phil Mickelson Shilling for Enbrel?”;